Vaccine News and Research

Latest Vaccine News and Research

Saint Louis University to participate in PPV23 vaccine trial for pneumonia

Saint Louis University is participating in a multi-site, National Institutes of Health-sponsored clinical trial in older adults of a new vaccine designed to protect against one of the most common types of pneumonia and related diseases such as bloodstream infections and meningitis.

16 Oct 2012

Taking technology from the lab to the patient: SMART Arm™: Hand of hope for stroke survivors

Creating a viable commercial product from its beginnings as a research concept through to a final product patients can use is a long, difficult and often expensive process. However, as David Henderson, the Managing Director of UniQuest, one of the leading technology transfer companies in the Asia Pacific region explains, a focus on patient needs is vital for developing a successful product.

15 Oct 2012

Therapeutic HPV16 and HPV18 vaccine ‘may eliminate infection’

A candidate vaccine against human papillomavirus serotypes 16 and 18 appears to induce robust immune responses to antigens, potentially leading to the elimination of virus-infected cells and regression of dysplasia, say US investigators.

15 Oct 2012

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

Researchers identify keys and doors of Anaplasmataceae tick-borne bacterium

Virginia Commonwealth University School of Medicine researchers have identified the "keys" and "doors" of a bacterium responsible for a series of tick-transmitted diseases. These findings may point researchers toward the development of a single vaccine that protects against members of an entire family of bacteria that cause disease in humans, domestic animals and livestock.

15 Oct 2012

Gardasil does not increase sexual activity in girls

The human papillomavirus (HPV) vaccine known as Gardasil is not associated with an increase in pregnancy, sexually transmitted infections, or contraceptive counseling, according to a Kaiser Permanente study published online today in the journal Pediatrics.

15 Oct 2012

Comparing animal and human cancer is of mutual benefit

A diagnosis of cancer once spelled the end for our animal companions but the launch today of a specialty cancer clinic, led by one of Australia’s leading veterinary oncologists at the University of Sydney, offers new hope.

14 Oct 2012

Financial Times features special report on NTDs

The Financial Times has published a special report on neglected tropical diseases (NTDs) featuring 10 articles examining issues including prevention, research, and treatment.

12 Oct 2012

Blog examines Japanese contribution to global vaccine efforts

In a post in Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Seth Berkley, CEO of the GAVI Alliance, examines "the contribution the Japanese people have made to immunization."

12 Oct 2012

Insight into how coeliac disease is triggered

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

12 Oct 2012

UCI neuro-oncologist to lead DCVax Phase II trial in glioblastoma multiforme

UC Irvine doctors are enrolling patients with the deadly brain tumor glioblastoma multiforme in a clinical trial of a vaccine that may prevent the cancer's return or spread after surgery.

11 Oct 2012

Study finds how MAIT cells recognize products of vitamin B synthesis from bacteria and yeast

An Australian research team has discovered how specialised immune cells recognise products of vitamin B synthesis that are unique to bacteria and yeast, triggering the body to fight infection.

11 Oct 2012

Genocea raises $30M in Series C financing round

Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $30 million in a Series C financing round.

10 Oct 2012

No link between HPV vaccination and increased sexual activity in adolescent girls

A study published in Vaccine reveals that contrary to recent discussions, the HPV vaccination does not increase sexual activity in adolescent girls.

10 Oct 2012

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.

10 Oct 2012

Pakistan to become first south Asian country to introduce pneumococcal vaccine

"Pakistan is set to become the first country in south Asia to introduce the pneumococcal vaccine to protect children against pneumonia, one of the biggest killers of children under five in the developing world," the Guardian reports.

10 Oct 2012

CRI, MedImmune partner to advance cancer immunotherapy research

The Cancer Research Institute (CRI), the Ludwig Institute for Cancer Research and MedImmune, the global biologics arm of AstraZeneca, today announced that they have signed a collaboration agreement to advance the research of immunotherapy in cancer.

10 Oct 2012

GSK, Aeras to advance clinical development of TB vaccine

Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01E adjuvant.

10 Oct 2012

Roundup: Labor activist's work for Blue Shield raises conflict concerns; R.I. to mandate flu shots for health workers; Minn. safety net hospitals brace for cuts

At a time when public-sector unions across the country are fighting to hold on to generous retirement and health benefits, one of the loudest voices standing up for their rights is Dave Low. A longtime labor activist, Low carries considerable clout as executive director of the California School Employees Assn., a 215,000-member union that represents bus drivers, custodians and other school workers.

10 Oct 2012

Myths about the influenza vaccine

With cold and flu season upon us, many companies have geared up for what is predicted to be a busy flu season producing 150 million doses of the influenza vaccine, up 17 million from last year.

9 Oct 2012

Vaccine News and Research

Latest Vaccine News and Research

Saint Louis University to participate in PPV23 vaccine trial for pneumonia

Taking technology from the lab to the patient: SMART Arm™: Hand of hope for stroke survivors

Therapeutic HPV16 and HPV18 vaccine ‘may eliminate infection’

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Researchers identify keys and doors of Anaplasmataceae tick-borne bacterium

Gardasil does not increase sexual activity in girls

Comparing animal and human cancer is of mutual benefit

Financial Times features special report on NTDs

Blog examines Japanese contribution to global vaccine efforts

Insight into how coeliac disease is triggered

UCI neuro-oncologist to lead DCVax Phase II trial in glioblastoma multiforme

Study finds how MAIT cells recognize products of vitamin B synthesis from bacteria and yeast

Genocea raises $30M in Series C financing round

No link between HPV vaccination and increased sexual activity in adolescent girls

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Pakistan to become first south Asian country to introduce pneumococcal vaccine

CRI, MedImmune partner to advance cancer immunotherapy research

GSK, Aeras to advance clinical development of TB vaccine

Roundup: Labor activist's work for Blue Shield raises conflict concerns; R.I. to mandate flu shots for health workers; Minn. safety net hospitals brace for cuts

Myths about the influenza vaccine

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in